The Clareon PanOptix Trifocal IOL: Visual Outcomes and Patient Satisfaction

NCT05346172 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-03-15

No results posted yet for this study

Summary

This will be a single arm, open-label, prospective study of patient-reported outcomes of patients with bilateral implantation of the Panoptix or Panoptix Toric implant.

Conditions

  • Cataract

Interventions

DEVICE

PanOptix or PanOptix Toric IOL

Patients who previously underwent cataract surgery with the PanOptix or PanOptix Toric IOL in both eyes.

Sponsors & Collaborators

  • Research Insight LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-17
Primary Completion
2023-03-10
Completion
2023-03-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05346172 on ClinicalTrials.gov